Synonym | Fibroblast Growth Factor 9; FGF-9; Glia-Activating Factor; GAF; Heparin-Binding Growth Factor 9; HBGF-9; FGF9 |
Species | Human |
Protein Accession | P31371 |
Purity | ≥95%, by SDS-PAGE (under reducing (R) & Non-reducing conditions, visualized by Coomassie staining) |
Endotoxin Level | ≤10 EU/mg by the LAL method |
Biological Activity | Measured in a cell proliferation assay using NIH3T3 mouse embryonicfibroblast cells. The ED50 for this effect is 1-3 ng/mL. Optimal concentration depends on cell type as well as the application orresearch objectives |
Expression System | CHO |
Fusion Tag | Tag Free |
Predicted Molecular Mass | 23.2 kDa |
Formulation | Lyophilized from a 0.22 μm-filtered solution containing PBS, 5% mannitoland 0.01% Tween 80, pH 7.4 |
Reconstitution | It is recommended to redissolve in sterile deionized water. |
Storage & Stability | 36 months at -20°C to -80°C in lyophilized state 6 months at -20°C to -80°C under sterile conditions after reconstitution 7-10 days at 2°C to 8°C under sterile conditions after reconstitution. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |